- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06098573
Development and Evaluation of HighAlert
October 9, 2024 updated by: Western University, Canada
Development and Evaluation of 'High Alert', a Mobile-Based Brief Intervention to Reduce Driving Under the Influence of Cannabis Among Youth
In Canada, youth ages 16-24 have the highest rates of cannabis use, impaired driving, and express the least concern for driving under the influence of cannabis (DUIC).
As such, developing effective and practical DUIC prevention efforts is crucial.
This study aims to evaluate the effects of 'High Alert' in reducing 3-month risky cannabis use and DUIC among young Ontarian drivers.
'High Alert' is an interactive web-based smartphone application developed by the research team with the feedback of experts and youth.
'High Alert' modules focus on recognizing what constitutes risky cannabis use, the effects of cannabis on driving, the risks of DUIC, and strategies to avoid DUIC.
A pilot randomized controlled trial will compare the effects of 'High Alert' with an active control (DUIC Information) and passive control (no contact).
Overall, effectively preventing DUIC among youth is critically needed and time-sensitive.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
103
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
London, Ontario, Canada, N6G 1G9
- Western University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion:
- ages 18-24
- valid Ontario driver's license
- access to a motor vehicle
- report DUIC at least three times in the past three months
- proficient in English
- have a smartphone they can complete the intervention with.
Exclusion Criteria:
- Individuals under 18 and those over 24
- resides outside Ontario
- non-drivers
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Program 1: High Alert
High Alert
|
Participants assigned to the 'High Alert' condition will complete four interactive modules using their smartphones.
These modules are hosted online via the Computerized Intervention Authoring Software, version 3.0 (https://www.cias.app
[CIAS]).
CIAS is a non- commercial, easily modifiable, web-based intervention platform used widely in the digital substance use literature.
No identifiable information is requested or stored in CIAS.
This program is only intended to deliver the content interactively.
None of the questions asked in CIAS will be treated as research data.
We will only report on the proportion of questions answered by participants (as a measure of adherence).
Individual responses to questions will not be analyzed nor reported on.
The purpose of the questions is for participants to engage with the content interactively
|
|
Active Comparator: Program 2: Information condition
Active Control- Information condition
|
Participants in the DUIC Information condition will receive a Qualtrics link with six infographics created to educate about DUIC.
Four infographics were retrieved from government websites, one was provided by a non-profit (i.e., Arrive Alive Drive Sober), and the research team created the final one.
After reviewing each infographic, participants will respond to a few questions about the infographic.
Questions asked to the DUIC Info Control will obtain data related to: seeing the infographic before, perceptions on the infographic content, aspects they liked/disliked, and likelihood to share with their peers.
All items will be treated as research data.
|
|
Placebo Comparator: No contact
Passive control- No contact
|
Participants in the passive control will receive no contact until the three and six-month follow-ups.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Past driving under the influence of cannabis
Time Frame: 3-months
|
"in the past three months, how many times have you driven within two hours of inhaling cannabis or within four hours of ingesting cannabis".
Continuous variable (min=0, no maximum).
Higher numbers indicate worse outcome (i.e., more impaired driving).
|
3-months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 1, 2023
Primary Completion (Actual)
September 10, 2024
Study Completion (Actual)
September 10, 2024
Study Registration Dates
First Submitted
October 18, 2023
First Submitted That Met QC Criteria
October 18, 2023
First Posted (Actual)
October 24, 2023
Study Record Updates
Last Update Posted (Actual)
October 15, 2024
Last Update Submitted That Met QC Criteria
October 9, 2024
Last Verified
October 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 123368
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cannabis
-
Anders Fink-Jensen, MD, DMSciNeurobiology Research Unit, RigshospitaletRecruitingCannabis Dependence | Cannabis Abuse | Cannabis Use Disorder | Cannabis Use Disorders | Cannabis AddictionDenmark
-
Centre hospitalier de l'Université de Montréal...CompletedCannabis | Cannabis Dependence | Cannabis Use | Cannabis Smoking | Cannabis Use, UnspecifiedCanada
-
Indiana UniversityNational Institute on Drug Abuse (NIDA)RecruitingMarijuana Abuse | Marijuana Use | Addiction | Substance Use | Cannabis Dependence | Substance Use Disorders | Cannabis Use | Substance Abuse | Addiction, Substance | Marijuana Dependence | Substance Dependence | Marijuana Smoking | Cannabis Abuse | Cannabis Use Disorder | Marijuana | Cannabis Intoxication | Substance Related... and other conditionsUnited States
-
Elias DakwarActive, not recruitingAddiction | Cannabis Dependence | Cannabis Use | Substance Abuse | Cannabis Abuse | Cannabis Use DisorderUnited States
-
Boston Children's HospitalNational Institute on Drug Abuse (NIDA)RecruitingCannabis Use | Cannabis Use Disorder | Cannabis IntoxicationUnited States
-
University of WashingtonNational Institute on Drug Abuse (NIDA)CompletedCannabis Dependence | Cannabis Abuse
-
University College, LondonMedical Research Council; InvicroCompletedCannabis | Cannabis Dependence | Cannabis Use | CBD | Adolescent Development | THC | Marijuana | Cannabis IntoxicationUnited Kingdom
-
Stanford UniversityNational Institute on Drug Abuse (NIDA)Not yet recruiting
-
Johns Hopkins Bloomberg School of Public HealthNational Institute on Drug Abuse (NIDA)Enrolling by invitation
-
The University of Hong KongRecruitingCannabis Dependence | Cannabis Abuse | Cannabis Use DisorderHong Kong
Clinical Trials on High Alert
-
Matrouh UniversityCompletedNurse's Role | Knowledge | Competence | Error Disclosure | Practice Nurse's ScopeEgypt
-
Geisinger ClinicNational Institute on Aging (NIA); Massachusetts Institute of Technology; National...Completed
-
Shin Kong Wu Ho-Su Memorial HospitalNational Taipei University of Nursing and Health SciencesRecruiting
-
Brigham and Women's HospitalSanofiCompletedDeep Vein Thrombosis | Venous Thromboembolism | Pulmonary Embolism | Prevention | ProphylaxisUnited States
-
Columbia UniversityEnrolling by invitationSepsis | Electronic Health Records | Clinical Decision Support SystemsUnited States
-
University of California, San FranciscoCompleted
-
Dana-Farber Cancer InstituteCompletedBreast Cancer | Gastrointestinal Cancer | Oral Cancer Directed Therapy | Oral ChemotherapyUnited States
-
Columbia UniversityEnrolling by invitationSepsis | Electronic Health Records | Clinical Decision Support SystemsUnited States
-
Imperial College LondonCompletedType1diabetesUnited Kingdom
-
Medical University of South CarolinaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...RecruitingMetabolic Dysfunction-associated Steatotic Liver DiseaseUnited States